NCT01514175 - A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Chronic Pelvic Pain

Interventions

DRUG

IV Ibuprofen

Patients will be randomized to receive 800 mg intravenous ibuprofen or 30 mg ketorolac; each of the two treatment groups will consist of 25 patients.

DRUG

IV Ketorolac

Patients will be randomized to receive 800 mg intravenous ibuprofen or 30 mg ketorolac; each of the two treatment groups will consist of 25 patients.

Trial Locations (1)

Culpeper Surgery Center, Culpeper